{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,5]],"date-time":"2026-07-05T10:24:17Z","timestamp":1783247057858,"version":"3.54.6"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100019652","name":"British University in Egypt","doi-asserted-by":"publisher","award":["YIRG2023-03"],"award-info":[{"award-number":["YIRG2023-03"]}],"id":[{"id":"10.13039\/501100019652","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.ejmech.2026.118808","type":"journal-article","created":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T03:47:13Z","timestamp":1774928833000},"page":"118808","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Novel methoxyquinazoline sulfonamide derivatives as angiogenesis inhibitors and radiosensitizers"],"prefix":"10.1016","volume":"311","author":[{"given":"Aiten M.","family":"Soliman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amira","family":"Khalil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mostafa M.","family":"Ghorab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2026.118808_bib1","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2026.118808_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.medidd.2019.100009","article-title":"Vascular endothelial growth factor receptor (VEGFR-2)\/KDR inhibitors: medicinal chemistry perspective","volume":"2","author":"Modi","year":"2019","journal-title":"Med. Drug Discov."},{"key":"10.1016\/j.ejmech.2026.118808_bib3","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.70295","article-title":"PI3K\/AKT\/mTOR axis in cancer: from pathogenesis to treatment","volume":"6","author":"Jiang","year":"2025","journal-title":"MedComm"},{"key":"10.1016\/j.ejmech.2026.118808_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2022.101364","article-title":"The PI3K\/Akt\/mTOR pathway in lung cancer; oncogenic alterations, therapeutic opportunities, challenges, and a glance at the application of nanoparticles","volume":"18","author":"Sanaei","year":"2022","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.ejmech.2026.118808_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10456-009-9160-6","article-title":"Anti-angiogenic tyrosine kinase inhibitors: what is their mechanism of action?","volume":"13","author":"Gotink","year":"2010","journal-title":"Angiogenesis"},{"key":"10.1016\/j.ejmech.2026.118808_bib6","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1007\/s12272-025-01545-1","article-title":"Targeting vascular endothelial growth receptor-2 (VEGFR-2): structural biology, functional insights, and therapeutic resistance","volume":"48","author":"Shah","year":"2025","journal-title":"Arch Pharm. Res. (Seoul)"},{"key":"10.1016\/j.ejmech.2026.118808_bib7","doi-asserted-by":"crossref","first-page":"10797","DOI":"10.1021\/jm301085w","article-title":"Vascular endothelial growth factor (VEGF) receptors: drugs and new inhibitors","volume":"55","author":"Musumeci","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118808_bib8","doi-asserted-by":"crossref","first-page":"18281","DOI":"10.1073\/pnas.1207759109","article-title":"Molecular conformations, interactions, and properties associated with drug efficiency and clinical performance among VEGFR TK inhibitors","volume":"109","author":"McTigue","year":"2012","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ejmech.2026.118808_bib9","first-page":"50","article-title":"Tumor angiogenesis and VEGFR-2: mechanism, pathways and current biological therapeutic interventions","volume":"22","author":"Shah","year":"2021","journal-title":"Curr. Drug Metabol."},{"key":"10.1016\/j.ejmech.2026.118808_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1307860","article-title":"Recent advances of anti-angiogenic inhibitors targeting VEGF\/VEGFR axis","volume":"14","author":"Wang","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.118808_bib11","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.intimp.2008.11.020","article-title":"The mechanisms on apoptosis by inhibiting VEGF expression in human breast cancer cells","volume":"9","author":"Ge","year":"2009","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.ejmech.2026.118808_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0028947","article-title":"Phosphorylation of Akt and ERK1\/2 is required for VEGF-A\/VEGFR2-induced proliferation and migration of lymphatic endothelium","volume":"6","author":"Dellinger","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2026.118808_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2021.128308","article-title":"Induction of apoptosis, cytotoxicity and radiosensitization by novel 3, 4-dihydroquinazolinone derivatives","volume":"49","author":"Soliman","year":"2021","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2026.118808_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106791","article-title":"New quinazoline sulfonamide derivatives as potential anticancer agents: identifying a promising hit with dual EGFR\/VEGFR-2 inhibitory and radiosensitizing activity","volume":"140","author":"Ghorab","year":"2023","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2026.118808_bib15","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1080\/14756366.2017.1334650","article-title":"VEGFR-2 inhibitors and apoptosis inducers: synthesis and molecular design of new benzo [g] quinazolin bearing benzenesulfonamide moiety","volume":"32","author":"Ghorab","year":"2017","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118808_bib16","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1080\/14756366.2019.1609469","article-title":"Novel sulfonamide benzoquinazolinones as dual EGFR\/HER2 inhibitors, apoptosis inducers and radiosensitizers","volume":"34","author":"Soliman","year":"2019","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118808_bib17","doi-asserted-by":"crossref","first-page":"6662","DOI":"10.3390\/ijms24076662","article-title":"Pharmacological targeting of Bcl-2 induces caspase 3-mediated cleavage of HDAC6 and regulates the autophagy process in colorectal cancer","volume":"24","author":"Yang","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2026.118808_bib18","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.bioorg.2018.12.040","article-title":"Synthesis, anticancer effect and molecular modeling of new thiazolylpyrazolyl coumarin derivatives targeting VEGFR-2 kinase and inducing cell cycle arrest and apoptosis","volume":"85","author":"Mohamed","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2026.118808_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.107062","article-title":"Iodoquinazoline-derived VEGFR-2 and EGFRT790M dual inhibitors: design, synthesis, molecular docking and anticancer evaluations","volume":"143","author":"Mohamed","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2026.118808_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115626","article-title":"Quinazoline-based VEGFR-2 inhibitors as potential anti-angiogenic agents: a contemporary perspective of SAR and molecular docking studies","volume":"259","author":"Moradi","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118808_bib21","doi-asserted-by":"crossref","first-page":"275","DOI":"10.4155\/fmc-2022-0297","article-title":"Antimicrobial, anticancer and immunomodulatory potential of new quinazolines bearing benzenesulfonamide moiety","volume":"15","author":"Ghorab","year":"2023","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118808_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112449","article-title":"Iodoquinazolinones bearing benzenesulfonamide as human carbonic anhydrase I, II, IX and XII inhibitors: synthesis, biological evaluation and radiosensitizing activity","volume":"200","author":"Soliman","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118808_bib23","doi-asserted-by":"crossref","first-page":"929","DOI":"10.4155\/fmc-2023-0342","article-title":"Quinazoline sulfonamide derivatives targeting MicroRNA-34a\/MDM4\/p53 apoptotic axis with radiosensitizing activity","volume":"16","author":"Soliman","year":"2024","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118808_bib24","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ejmech.2017.09.061","article-title":"Discovery of Benzo [g] quinazolin benzenesulfonamide derivatives as dual EGFR\/HER2 inhibitors","volume":"141","author":"Alsaid","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118808_bib25","doi-asserted-by":"crossref","first-page":"5341","DOI":"10.3390\/molecules29225341","article-title":"Targeting vascular endothelial growth factor receptor 2 (VEGFR-2): latest insights on synthetic strategies","volume":"29","author":"Marques","year":"2024","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2026.118808_bib26","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1080\/14756366.2020.1854243","article-title":"Synthesis of some quinazolinones inspired from the natural alkaloid L-norephedrine as EGFR inhibitors and radiosensitizers","volume":"36","author":"Ghorab","year":"2021","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118808_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104618","article-title":"Biological evaluation, radiosensitizing activity and structural insights of novel halogenated quinazoline-sulfonamide conjugates as selective human carbonic anhydrases IX\/XII inhibitors","volume":"107","author":"Ghorab","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2026.118808_bib28","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1038\/sj.bjc.6602603","article-title":"ZD6474\u2013a novel inhibitor of VEGFR and EGFR tyrosine kinase activity","volume":"92","author":"Ryan","year":"2005","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ejmech.2026.118808_bib29","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1007\/s10637-024-01476-6","article-title":"Clinical research progress of fruquintinib in the treatment of malignant tumors","volume":"42","author":"Zhao","year":"2024","journal-title":"Invest. N. Drugs"},{"key":"10.1016\/j.ejmech.2026.118808_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2021.127788","article-title":"Discovery of novel VEGFR-2 inhibitors embedding 6, 7-dimethoxyquinazoline and diarylamide fragments","volume":"36","author":"Wang","year":"2021","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2026.118808_bib31","doi-asserted-by":"crossref","first-page":"26325","DOI":"10.1039\/D4RA04828H","article-title":"S-Alkylated quinazolin-4 (3 H)-ones as dual EGFR\/VEGFR-2 kinases inhibitors: design, synthesis, anticancer evaluation and docking study","volume":"14","author":"Tawfik","year":"2024","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2026.118808_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114912","article-title":"Antiproliferative, antiangiogenic and apoptotic effect of new hybrids of quinazoline-4 (3H)-ones and sulfachloropyridazine","volume":"245","author":"Zahran","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118808_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103422","article-title":"Design, synthesis, molecular modeling, in vivo studies and anticancer evaluation of quinazolin-4 (3H)-one derivatives as potential VEGFR-2 inhibitors and apoptosis inducers","volume":"94","author":"Mahdy","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2026.118808_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.102956","article-title":"Exploration of N-alkyl-2-[(4-oxo-3-(4-sulfamoylphenyl)-3, 4-dihydroquinazolin-2-yl) thio] acetamide derivatives as anticancer and radiosensitizing agents","volume":"88","author":"Soliman","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2026.118808_bib35","doi-asserted-by":"crossref","first-page":"2992","DOI":"10.3390\/molecules26102992","article-title":"Synthesis, anticancer screening of some novel trimethoxy quinazolines and VEGFR2, EGFR tyrosine kinase inhibitors assay; molecular docking studies","volume":"26","author":"Altamimi","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2026.118808_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.117771","article-title":"Chromanone derivatives: evaluating selective anticancer activity across human cell lines","volume":"295","author":"Sobiesiak","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118808_bib37","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s12079-016-0352-8","article-title":"VEGF-A\/VEGFR2 signaling network in endothelial cells relevant to angiogenesis","volume":"10","author":"Abhinand","year":"2016","journal-title":"J. Cell Commun. Signal."},{"key":"10.1016\/j.ejmech.2026.118808_bib38","article-title":"PI3K\/Akt\/mTOR pathway and its role in cancer therapeutics: are we making headway?","volume":"12","author":"Peng","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ejmech.2026.118808_bib39","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.ejmech.2017.04.028","article-title":"Aromatase inhibitors and apoptotic inducers: design, synthesis, anticancer activity and molecular modeling studies of novel phenothiazine derivatives carrying sulfonamide moiety as hybrid molecules","volume":"134","author":"Ghorab","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118808_bib40","first-page":"4827","article-title":"Evaluation of a soluble tetrazolium\/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines","volume":"48","author":"Scudiero","year":"1988","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejmech.2026.118808_bib41","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.bioorg.2018.07.015","article-title":"Dual EGFR\/HER2 inhibitors and apoptosis inducers: new benzo [g] quinazoline derivatives bearing benzenesulfonamide as anticancer and radiosensitizers","volume":"80","author":"Ghorab","year":"2018","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2026.118808_bib42","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1007\/s00066-021-01835-9","article-title":"Preclinical evaluation of PEGylated liposomal doxorubicin as an effective radiosensitizer in chemoradiotherapy for lung cancer","volume":"197","author":"Chen","year":"2021","journal-title":"Strahlenther. Onkol."},{"key":"10.1016\/j.ejmech.2026.118808_bib43","first-page":"7","article-title":"Chemosensitization and radiosensitization of a lung cancer cell line A549 induced by a composite polymer micelle","volume":"22","author":"Xu","year":"2016","journal-title":"Discov. Med."},{"key":"10.1016\/j.ejmech.2026.118808_bib44","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1177\/030089161309900210","article-title":"Sorafenib acts synergistically in combination with radiotherapy without causing intestinal damage in colorectal cancer","volume":"99","author":"Jeong","year":"2013","journal-title":"Tumori"},{"key":"10.1016\/j.ejmech.2026.118808_bib45","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2014.415","article-title":"PI3K\/Akt\/mTOR pathway inhibitors enhance radiosensitivity in radioresistant prostate cancer cells through inducing apoptosis, reducing autophagy, suppressing NHEJ and HR repair pathways","volume":"5","author":"Chang","year":"2014","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejmech.2026.118808_bib46","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.3390\/cancers15092529","article-title":"Regulation of VEGFR2 and AKT signaling by Musashi-2 in lung cancer","volume":"15","author":"Bychkov","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ejmech.2026.118808_bib47","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.12356","article-title":"A novel role for apatinib in enhancing radiosensitivity in non-small cell lung cancer cells by suppressing the AKT and ERK pathways","volume":"9","author":"Li","year":"2021","journal-title":"PeerJ"},{"key":"10.1016\/j.ejmech.2026.118808_bib48","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.ejmech.2026.118808_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104350","article-title":"Design, green synthesis, molecular docking and anticancer evaluations of diazepam bearing sulfonamide moieties as VEGFR-2 inhibitors","volume":"104","author":"Saleh","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2026.118808_bib50","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1080\/14756366.2017.1279155","article-title":"Synthesis and in vitro anti-proliferative activity of some novel isatins conjugated with quinazoline\/phthalazine hydrazines against triple-negative breast cancer MDA-MB-231 cells as apoptosis-inducing agents","volume":"32","author":"Eldehna","year":"2017","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118808_bib51","series-title":"Molecular Operating Environment","year":"2014"},{"key":"10.1016\/j.ejmech.2026.118808_bib52","doi-asserted-by":"crossref","first-page":"36636","DOI":"10.1074\/jbc.M113.507756","article-title":"Potent reversible inhibition of myeloperoxidase by aromatic hydroxamates","volume":"288","author":"Forbes","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2026.118808_bib53","doi-asserted-by":"crossref","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2026.118808_bib54","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2307\/3001913","article-title":"Comparing individual means in the analysis of variance","author":"Tukey","year":"1949","journal-title":"Biometrics"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426002539?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426002539?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T13:44:02Z","timestamp":1781271842000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523426002539"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":54,"alternative-id":["S0223523426002539"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.118808","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel methoxyquinazoline sulfonamide derivatives as angiogenesis inhibitors and radiosensitizers","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.118808","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118808"}}